BerGenBio

Selective AXL inhibitors

Home  /  Investors  /  Investor Relations Contacts

For Investor Relations Information Or Questions Please Contact:

Richard Godfrey

Chief Executive Officer

Phone: +47 559 61 159

Email: ir@bergenbio.com

Rune Skeie

Chief Financial Officer

Phone: +47 917 86 513‬

Email: rune.skeie@bergenbio.com